Mamounas, E. P., Bandos, H., Lembersky, B. C., Jeong, J., Geyer, C. E., Rastogi, P., . . . Wolmark, N. (2018). A randomized trial of five years of letrozole versus placebo after aromatase inhibitor-based therapy: NRG Oncology/NSABP B-42. Lancet Oncol.
Citação norma ChicagoMamounas, Eleftherios P., et al. "A Randomized Trial of Five Years of Letrozole Versus Placebo After Aromatase Inhibitor-based Therapy: NRG Oncology/NSABP B-42." Lancet Oncol 2018.
ציטוט MLAMamounas, Eleftherios P., et al. "A Randomized Trial of Five Years of Letrozole Versus Placebo After Aromatase Inhibitor-based Therapy: NRG Oncology/NSABP B-42." Lancet Oncol 2018.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.